In October 2024, multi-industry stakeholders gathered for the DCRI Think Tank Anti-Obesity Pharmacotherapy: Need for Guidance, Access, and Equity, which focused on aligning and advancing the field of obesity medications (OMs). Their insights and collaboration resulted in the article Obesity Pharmacotherapy: An Urgent Need for Progressing Science, Access, and Equity published in the journal JACC: Advances.

The city of Durham formally recognized the importance of clinical research on May 18, when Mayor Leonardo Williams proclaimed May 20, 2026, as Clinical Trials Day during a Durham City Council meeting. The proclamation emphasized the role that clinical trials play in public health by advancing understanding of health and supporting the development of safe and effective treatments.

Duke University has been awarded $12.9 million from the Patient-Centered Outcomes Research Institute (PCORI) for a new clinical trial aimed at improving the standard of care for autistic children with chronic digestive discomfort.

The Antibacterial Resistance Leadership Group (ARLG), based at the Duke Clinical Research Institute, was prominently featured at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress 2026, with two of its multicenter studies selected for a special late-breaking session.   Of the four studies chosen for the high-profile session, two were conducted through ARLG, highlighting the group’s growing global influence in advancing evidence to address the escalating crisis of antibiotic-resistant infections.